Hepatotoxicity of Antituberculosis Therapy (HAT) Study
Condition(s):Chemical and Drug Induced Liver InjuryLast Updated:November 12, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Chemical and Drug Induced Liver InjuryLast Updated:November 12, 2019Unknown status
Condition(s):Tuberculous UveitisLast Updated:February 23, 2024Enrolling by invitation
Condition(s):Tuberculosis, PulmonaryLast Updated:February 8, 2023Withdrawn
Condition(s):Tuberculous MeningitisLast Updated:February 1, 2021Unknown status
Condition(s):Tuberculosis InfectionLast Updated:December 14, 2023Recruiting
Condition(s):HIV Infections; TuberculosisLast Updated:July 17, 2020Completed
Condition(s):HIV Infections; TuberculosisLast Updated:December 27, 2021Completed
Condition(s):Tuberculosis; Uveitis (Manifestation); Anti-Tuberculous Drug Reaction; Tuberculous UveitisLast Updated:February 28, 2024Recruiting
Condition(s):HIV/TB CoinfectionLast Updated:March 1, 2023Recruiting
Condition(s):Hepatitis; TuberculosisLast Updated:August 31, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.